The nonsense-mediated mRNA decay (NMD) pathway rapidly detects and degrades mRNA containing premature termination codons (PTCs). UP-frameshift 1 (UPF1), the master regulator of the NMD process, has two alternatively-spliced isoforms; one carries 353-GNEDLVIIWLR-363 insertion in the 'regulatory loop (involved in mRNA binding)'. Such insertion can induce catalytic and/or ATPase activity, as determined experimentally; however, the kinetics and molecular level information are not fully understood. Herein, applying all-atom molecular dynamics, we probe the binding specificity of UPF1 with different GC- and AU-rich mRNA motifs and the influence of insertion to the viable control over UPF1 catalytic activity. Our results indicate two distinct conformations between 1B and RecA2 domains of UPF1: 'open (isoform_2; without insertion)' and 'closed (isoform_1; with insertion)'. These structural movements correspond to an important stacking pattern in mRNA motifs, i.e., absence of stack formation in mRNA, with UPF1 isoform_2 results in the 'open conformation'. Particularly, for UPF1 isoform_1, the increased distance between 1B and RecA2 domains has resulted in reducing the mRNA-UPF1 interactions. Lower fluctuating GC-rich mRNA motifs have better binding with UPF1, compared with AU-rich sequences. Except CCUGGGG, all other GC-rich motifs formed a 4-stack pattern with UPF1. High occupancy R363, D364, T627, and G862 residues were common binding GC-rich motifs, as were R363, N535, and T627 for the AU-rich motifs. The GC-rich motifs behave distinctly when bound to either of the isoforms; lower stability was observed with UPF1 isoform_2. The cancer-associated UPF1 variants (P533L/T and A839T) resulted in decreased protein-mRNA binding efficiency. Lack of mRNA stacking poses in the UPF1P533T system significantly decreased UPF1-mRNA binding efficiency and increased distance between 1B-RecA2. These novel findings can serve to further inform NMD-associated mechanistic and kinetic studies.

Department of Medical Biosciences Umeå University Building 6M 90185 Umeå Sweden

Inserm UMRS1131 Institut de Génétique Moléculaire Université Paris 7 Hôpital St Louis F 75010 Paris France

Institute of Genetics and Cancer University of Edinburgh Edinburgh EH4 2XR UK

International Centre for Cancer Vaccine Science University of Gdansk ul Kładki 24 80 822 Gdansk Poland

Regional Centre for Applied Molecular Oncology Masaryk Memorial Cancer Institute Zlutykopec 7 65653 Brno Czech Republic

Zobrazit více v PubMed

Stefani M., Dobson C.M. Protein aggregation and aggregate toxicity: New insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 2003;81:678–699. doi: 10.1007/s00109-003-0464-5. PubMed DOI

Gregersen N., Bross P., Vang S., Christensen J.H. Protein Misfolding and Human Disease. Annu. Rev. Genom. Hum. Genet. 2006;7:103–124. doi: 10.1146/annurev.genom.7.080505.115737. PubMed DOI

Zimmermann R., Müller L., Wullich B. Protein transport into the endoplasmic reticulum: Mechanisms and pathologies. Trends Mol. Med. 2006;12:567–573. doi: 10.1016/j.molmed.2006.10.004. PubMed DOI

Hebert D.N., Molinari M. In and Out of the ER: Protein Folding, Quality Control, Degradation, and Related Human Diseases. Physiol. Rev. 2007;87:1377–1408. doi: 10.1152/physrev.00050.2006. PubMed DOI

Jarjanazi H., Savas S., Pabalan N., Dennis J.W., Ozcelik H. Biological implications of SNPs in signal peptide domains of human proteins. Proteins Struct. Funct. Bioinform. 2007;70:394–403. doi: 10.1002/prot.21548. PubMed DOI

Hipp M.S., Park S.-H., Hartl F.U. Proteostasis impairment in protein-misfolding and -aggregation diseases. Trends Cell Biol. 2014;24:506–514. doi: 10.1016/j.tcb.2014.05.003. PubMed DOI

Karamyshev A.L., Karamysheva Z.N. Lost in Translation: Ribosome-Associated mRNA and Protein Quality Controls. Front. Genet. 2018;9:431. doi: 10.3389/fgene.2018.00431. PubMed DOI PMC

Karamyshev A.L., Tikhonova E.B., Karamysheva Z.N. Translational Control of Secretory Proteins in Health and Disease. Int. J. Mol. Sci. 2020;21:2538. doi: 10.3390/ijms21072538. PubMed DOI PMC

Welch E.M., Jacobson A. An internal open reading frame triggers nonsense-mediated decay of the yeast SPT10 mRNA. EMBO J. 1999;18:6134–6145. doi: 10.1093/emboj/18.21.6134. PubMed DOI PMC

Doma M.K., Parker R. RNA Quality Control in Eukaryotes. Cell. 2007;131:660–668. doi: 10.1016/j.cell.2007.10.041. PubMed DOI

Shoemaker C.J., Green R. Translation drives mRNA quality control. Nat. Struct. Mol. Biol. 2012;19:594–601. doi: 10.1038/nsmb.2301. PubMed DOI PMC

Popp M.W.-L., Maquat L.E. Organizing Principles of Mammalian Nonsense-Mediated mRNA Decay. Annu. Rev. Genet. 2013;47:139–165. doi: 10.1146/annurev-genet-111212-133424. PubMed DOI PMC

Lewis B.P., Green R., Brenner S.E. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc. Natl. Acad. Sci. USA. 2002;100:189–192. doi: 10.1073/pnas.0136770100. PubMed DOI PMC

Nicholson P., Mühlemann O. Cutting the nonsense: The degradation of PTC-containing mRNAs. Biochem. Soc. Trans. 2010;38:1615–1620. doi: 10.1042/BST0381615. PubMed DOI

Frischmeyer P.A., Dietz H.C. Nonsense-mediated mRNA decay in health and disease. Hum. Mol. Genet. 1999;8:1893–1900. doi: 10.1093/hmg/8.10.1893. PubMed DOI

Mort M., Ivanov D., Cooper D.N., Chuzhanova N.A. A meta-analysis of nonsense mutations causing human genetic disease. Hum. Mutat. 2008;29:1037–1047. doi: 10.1002/humu.20763. PubMed DOI

Hurt J.A., Robertson A.D., Burge C.B. Global analyses of UPF1 binding and function reveal expanded scope of nonsense-mediated mRNA decay. Genome Res. 2013;23:1636–1650. doi: 10.1101/gr.157354.113. PubMed DOI PMC

Colombo M., Karousis E., Bourquin J., Bruggmann R., Mühlemann O. Transcriptome-wide identification of NMD-targeted human mRNAs reveals extensive redundancy between SMG6- and SMG7-mediated degradation pathways. RNA. 2016;23:189–201. doi: 10.1261/rna.059055.116. PubMed DOI PMC

Imamachi N., Salam K.A., Suzuki Y., Akimitsu N. A GC-rich sequence feature in the 3′ UTR directs UPF1-dependent mRNA decay in mammalian cells. Genome Res. 2016;27:407–418. doi: 10.1101/gr.206060.116. PubMed DOI PMC

Karousis E.D., Gurzeler L.A., Annibaldis G., Dreos R., Mühlemann O. Human NMD ensues independently of stable ribosome stalling. Nat. Commun. 2020;11:4134. doi: 10.1038/s41467-020-17974-z. PubMed DOI PMC

Yepiskoposyan H., Aeschimann F., Nilsson D., Okoniewski M., Mühlemann O. Autoregulation of the nonsense-mediated mRNA decay pathway in human cells. RNA. 2011;17:2108–2118. doi: 10.1261/rna.030247.111. PubMed DOI PMC

Thoren L.A., Nørgaard G.A., Weischenfeldt J., Waage J., Jakobsen J.S., Damgaard I., Bergström F.C., Blom A.M., Borup R., Bisgaard H.C., et al. UPF2 is a critical regulator of liver development, function and regeneration. PLoS ONE. 2010;5:e11650. doi: 10.1371/journal.pone.0011650. PubMed DOI PMC

Kuzmiak H.A., Maquat L.E. Applying nonsense-mediated mRNA decay research to the clinic: Progress and challenges. Trends Mol. Med. 2006;12:306–316. doi: 10.1016/j.molmed.2006.05.005. PubMed DOI

Khajavi M., Inoue K., Lupski J.R. Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur. J. Hum. Genet. 2006;14:1074–1081. doi: 10.1038/sj.ejhg.5201649. PubMed DOI

A Holbrook J., Neu-Yilik G., Hentze M., E Kulozik A. Nonsense-mediated decay approaches the clinic. Nat. Genet. 2004;36:801–808. doi: 10.1038/ng1403. PubMed DOI

Czaplinski K., Weng Y., Hagan K.W., Peltz S.W. Purification and characterization of the Upf1 protein: A factor involved in translation and mRNA degradation. RNA. 1995;1:610–623. PubMed PMC

Atkin A.L., Altamura N., Leeds P., Culbertson M.R. The majority of yeast UPF1 co-localizes with polyribosomes in the cytoplasm. Mol. Biol. Cell. 1995;6:611–625. doi: 10.1091/mbc.6.5.611. PubMed DOI PMC

Weng Y., Czaplinski K., Peltz S.W. Identification and characterization of mutations in the UPF1 gene that affect nonsense suppression and the formation of the Upf protein complex but not mRNA turnover. Mol. Cell. Biol. 1996;16:5491–5506. doi: 10.1128/MCB.16.10.5491. PubMed DOI PMC

Bhattacharya A., Czaplinski K., Trifillis P., He F., Jacobson A., Peltz S.W. Characterization of the biochemical properties of the human Upf1 gene product that is involved in nonsense-mediated mRNA decay. RNA. 2000;6:1226–1235. doi: 10.1017/S1355838200000546. PubMed DOI PMC

Sun X., Perlick H.A., Dietz H.C., Maquat L.E. A mutated human homologue to yeast Upf1 protein has a dominant-negative effect on the decay of nonsense-containing mRNAs in mammalian cells. Proc. Natl. Acad. Sci. USA. 1998;95 doi: 10.1073/pnas.95.17.10009. PubMed DOI PMC

Lasalde C., Rivera A.V., León A.J., González-Feliciano J.A., Estrella L.A., Rodríguez-Cruz E.N., Correa M.E., Cajigas I.J., Bracho D.P., Vega I.E., et al. Identification and functional analysis of novel phosphorylation sites in the RNA surveillance protein Upf1. Nucleic Acids Res. 2013;42:1916–1929. doi: 10.1093/nar/gkt1049. PubMed DOI PMC

Weng Y., Czaplinski K., Peltz S.W. Genetic and biochemical characterization of mutations in the ATPase and helicase regions of the Upf1 protein. Mol. Cell. Biol. 1996;16:5477–5490. doi: 10.1128/MCB.16.10.5477. PubMed DOI PMC

Atkin A.L., Schenkman L.R., Eastham M., Dahlseid J.N., Lelivelt M.J., Culbertson M.R. Relationship between Yeast Polyribosomes and Upf Proteins Required for Nonsense mRNA Decay. J. Biol. Chem. 1997;272:22163–22172. doi: 10.1074/jbc.272.35.22163. PubMed DOI

Weng Y., Czaplinski K., Peltz S.W. ATP is a cofactor of the Upf1 protein that modulates its translation termination and RNA binding activities. RNA. 1998;4:205–214. PubMed PMC

Kadlec J., Guilligay D., Ravelli R.B., Cusack S. Crystal structure of the UPF2-interacting domain of nonsense-mediated mRNA decay factor UPF1. RNA. 2006;12:1817–1824. doi: 10.1261/rna.177606. PubMed DOI PMC

He F., Brown A.H., Jacobson A. Upf1p, Nmd2p, and Upf3p are interacting components of the yeast nonsense-mediated mRNA decay pathway. Mol. Cell. Biol. 1997;17:1580–1594. doi: 10.1128/MCB.17.3.1580. PubMed DOI PMC

Chakrabarti S., Jayachandran U., Bonneau F., Fiorini F., Basquin C., Domcke S., Le Hir H., Conti E. Molecular mechanisms for the RNA-dependent ATPase activity of Upf1 and its regulation by Upf2. Mol. Cell. 2011;41:693–703. doi: 10.1016/j.molcel.2011.02.010. PubMed DOI

Serin G., Gersappe A., Black J.D., Aronoff R., Maquat L.E. Identification and Characterization of Human Orthologues to Saccharomyces cerevisiae Upf2 Protein and Upf3 Protein (Caenorhabditis elegans SMG-4) Mol. Cell. Biol. 2001;21:209–223. doi: 10.1128/MCB.21.1.209-223.2001. PubMed DOI PMC

Chamieh H., Ballut L., Bonneau F., Le Hir H. NMD factors UPF2 and UPF3 bridge UPF1 to the exon junction complex and stimulate its RNA helicase activity. Nat. Struct. Mol. Biol. 2007;15:85–93. doi: 10.1038/nsmb1330. PubMed DOI

Kalathiya U., Padariya M., Pawlicka K., Verma C.S., Houston D., Hupp T.R., Alfaro J.A. Hupp Insights into the Effects of Cancer Associated Mutations at the UPF2 and ATP-Binding Sites of NMD Master Regulator: UPF1. Int. J. Mol. Sci. 2019;20:5644. doi: 10.3390/ijms20225644. PubMed DOI PMC

Kashima I., Yamashita A., Izumi N., Kataoka N., Morishita R., Hoshino S., Ohno M., Dreyfuss G., Ohno S. Binding of a novel SMG-1-Upf1-eRF1-eRF3 complex (SURF) to the exon junction complex triggers Upf1 phosphorylation and nonsense-mediated mRNA decay. Genes Dev. 2006;20:355–367. doi: 10.1101/gad.1389006. PubMed DOI PMC

Ruiz-Echevarría M.J., González C.I., Peltz S.W. Identifying the right stop: Determining how the surveillance complex recognizes and degrades an aberrant mRNA. EMBO J. 1998;17:575–589. doi: 10.1093/emboj/17.2.575. PubMed DOI PMC

Hwang J., Sato H., Tang Y., Matsuda D., Maquat L.E. UPF1 association with the cap-binding protein, CBP80, promotes nonsense-mediated mRNA decay at two distinct steps. Mol. Cell. 2010;39:396–409. doi: 10.1016/j.molcel.2010.07.004. PubMed DOI PMC

Amrani N., Ganesan R., Kervestin S., Mangus D.A., Ghosh S., Jacobson A. A faux 3′-UTR promotes aberrant termination and triggers nonsense- mediated mRNA decay. Nature. 2004;432:112–118. doi: 10.1038/nature03060. PubMed DOI

Lejeune F., E Maquat L. Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells. Curr. Opin. Cell Biol. 2005;17:309–315. doi: 10.1016/j.ceb.2005.03.002. PubMed DOI

Kuroha K., Tatematsu T., Inada T. Upf1 stimulates degradation of the product derived from aberrant messenger RNA containing a specific nonsense mutation by the proteasome. EMBO Rep. 2009;10:1265–1271. doi: 10.1038/embor.2009.200. PubMed DOI PMC

Carter M.S., Li S., Wilkinson M.F. A splicing-dependent regulatory mechanism that detects translation signals. EMBO J. 1996;15:5965–5975. doi: 10.1002/j.1460-2075.1996.tb00983.x. PubMed DOI PMC

Kervestin S., Li C., Buckingham R., Jacobson A. Testing the faux-UTR model for NMD: Analysis of Upf1p and Pab1p competition for binding to eRF3/Sup35p. Biochimie. 2012;94:1560–1571. doi: 10.1016/j.biochi.2011.12.021. PubMed DOI PMC

Ohnishi T., Yamashita A., Kashima I., Schell T., Anders K., Grimson A., Hachiya T., Hentze M., Anderson P., Ohno S. Phosphorylation of hUPF1 Induces Formation of mRNA Surveillance Complexes Containing hSMG-5 and hSMG-7. Mol. Cell. 2003;12:1187–1200. doi: 10.1016/S1097-2765(03)00443-X. PubMed DOI

Hosoda N., Kim Y.K., Lejeune F., E Maquat L. CBP80 promotes interaction of Upf1 with Upf2 during nonsense-mediated mRNA decay in mammalian cells. Nat. Struct. Mol. Biol. 2005;12:893–901. doi: 10.1038/nsmb995. PubMed DOI

González C.I., Ruiz-Echevarría M.J., Vasudevan S., Henry M.F., Peltz S.W. The yeast hnRNP-like protein Hrp1/Nab4 marks a transcript for nonsense-mediated mRNA decay. Mol. Cell. 2000;5:489–499. doi: 10.1016/S1097-2765(00)80443-8. PubMed DOI

Lykke-Andersen J., Shu M.-D., Steitz J.A. Human Upf Proteins Target an mRNA for Nonsense-Mediated Decay When Bound Downstream of a Termination Codon. Cell. 2000;103:1121–1131. doi: 10.1016/S0092-8674(00)00214-2. PubMed DOI

Shibuya T., Tange T., Stroupe M.E., Moore M.J. Mutational analysis of human eIF4AIII identifies regions necessary for exon junction complex formation and nonsense-mediated mRNA decay. RNA. 2006;12:360–374. doi: 10.1261/rna.2190706. PubMed DOI PMC

Gehring N.H., Kunz J.B., Neu-Yilik G., Breit S., Viegas M.H., Hentze M.W., Kulozik A.E. Exon-Junction Complex Components Specify Distinct Routes of Nonsense-Mediated mRNA Decay with Differential Cofactor Requirements. Mol. Cell. 2005;20:65–75. doi: 10.1016/j.molcel.2005.08.012. PubMed DOI

Yamashita A., Ohnishi T., Kashima I., Taya Y., Ohno S. Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the regulation of nonsense-mediated mRNA decay. Genes Dev. 2001;15:2215–2228. doi: 10.1101/gad.913001. PubMed DOI PMC

Popp M.W., Maquat L.E. Leveraging Rules of Nonsense-Mediated mRNA Decay for Genome Engineering and Personalized Medicine. Cell. 2016;165:1319–1322. doi: 10.1016/j.cell.2016.05.053. PubMed DOI PMC

Conti E., Izaurralde E. Nonsense-mediated mRNA decay: Molecular insights and mechanistic variations across species. Curr. Opin. Cell Biol. 2005;17:316–325. doi: 10.1016/j.ceb.2005.04.005. PubMed DOI

Amrani N., Sachs M., Jacobson A.J. Early nonsense: mRNA decay solves a translational problem. Nat. Rev. Mol. Cell Biol. 2006;7:415–425. doi: 10.1038/nrm1942. PubMed DOI

Amrani N., Dong S., He F., Ganesan R., Ghosh S., Kervestin S., Li C., Mangus D.A., Spatrick P., Jacobson A. Aberrant termination triggers nonsense-mediated mRNA decay. Biochem. Soc. Trans. 2006;34:39–42. doi: 10.1042/BST0340039. PubMed DOI

Rebbapragada I., Lykke-Andersen J. Execution of nonsense-mediated mRNA decay: What defines a substrate? Curr. Opin. Cell Biol. 2019;21:394–402. doi: 10.1016/j.ceb.2009.02.007. PubMed DOI

Behm-Ansmant I., Kashima I., Rehwinkel J., Saulière J., Wittkopp N., Izaurralde E. mRNA quality control: An ancient machinery recognizes and degrades mRNAs with nonsense codons. FEBS Lett. 2007;581:2845–2853. doi: 10.1016/j.febslet.2007.05.027. PubMed DOI

Le Hir H., Gatfield D., Izaurralde E., Moore M.J. The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. EMBO J. 2001;20:4987–4997. doi: 10.1093/emboj/20.17.4987. PubMed DOI PMC

Isken O., Kim Y.K., Hosoda N., Mayeur G.L., Hershey J.W., Maquat L.E. Upf1 Phosphorylation Triggers Translational Repression during Nonsense-Mediated mRNA Decay. Cell. 2008;133:314–327. doi: 10.1016/j.cell.2008.02.030. PubMed DOI PMC

Huntzinger E., Braun J.E., Heimstädt S., Zekri L., Izaurralde E. Two PABPC1-binding sites in GW182 proteins promote miRNA-mediated gene silencing. EMBO J. 2010;29:4146–4160. doi: 10.1038/emboj.2010.274. PubMed DOI PMC

Kebaara B.W., Atkin A.L. Long 3′-UTRs target wild-type mRNAs for nonsense-mediated mRNA decay in Saccharomyces cerevisiae. Nucleic Acids Res. 2009;37:2771–2778. doi: 10.1093/nar/gkp146. PubMed DOI PMC

Muhlrad D., Parker R. Aberrant mRNAs with extended 3′ UTRs are substrates for rapid degradation by mRNA surveillance. RNA. 1999;5:1299–1307. doi: 10.1017/S1355838299990829. PubMed DOI PMC

Clerici M., Mourão A., Gutsche I., Gehring N.H., Hentze M., Kulozik A., Kadlec J., Sattler M., Cusack S. Unusual bipartite mode of interaction between the nonsense-mediated decay factors, UPF1 and UPF2. EMBO J. 2009;28:2293–2306. doi: 10.1038/emboj.2009.175. PubMed DOI PMC

Safaee N., Kozlov G., Noronha A.M., Xie J., Wilds C., Gehring K. Interdomain Allostery Promotes Assembly of the Poly(A) mRNA Complex with PABP and eIF4G. Mol. Cell. 2012;48:375–386. doi: 10.1016/j.molcel.2012.09.001. PubMed DOI

Kelley L.A., Sternberg M.J.E. Protein structure prediction on the Web: A case study using the Phyre server. Nat. Protoc. 2009;4:363–371. doi: 10.1038/nprot.2009.2. PubMed DOI

Wu C., Roy B., He F., Jacobson A. Nonsense suppression position effect implicates poly(A)-binding protein in the regulation of translation termination. SSRN Electron. J. 2019 doi: 10.2139/ssrn.3483671. DOI

Gowravaram M., Bonneau F., Kanaan J., Maciej V.D., Fiorini F., Raj S., Croquette V., Le Hir H., Chakrabarti S. A conserved structural element in the RNA helicase UPF1 regulates its catalytic activity in an isoform-specific manner. Nucleic Acids Res. 2018;46:2648–2659. doi: 10.1093/nar/gky040. PubMed DOI PMC

Kurosaki T., Maquat L.E. Rules that govern UPF1 binding to mRNA 3′ UTRs. Proc. Natl. Acad. Sci. USA. 2013;110:3357–3362. doi: 10.1073/pnas.1219908110. PubMed DOI PMC

Hamann F., Enders M., Ficner R. Structural basis for RNA translocation by DEAH-box ATPases. Nucleic Acids Res. 2019;47:4349–4362. doi: 10.1093/nar/gkz150. PubMed DOI PMC

Shi M., Zhang H., Wang L., Zhu C., Sheng K., Du Y., Wang K., Dias A., Chen S., Whitman M., et al. Premature termination codons are recognized in the nucleus in a reading-frame-dependent manner. Cell Discov. 2015;1:15001. doi: 10.1038/celldisc.2015.1. PubMed DOI PMC

Hogg J.R., Goff S.P. Upf1 Senses 3′UTR Length to Potentiate mRNA Decay. Cell. 2010;143:379–389. doi: 10.1016/j.cell.2010.10.005. PubMed DOI PMC

Zünd D., Gruber A.R., Zavolan M., Mühlemann O. Translation-dependent displacement of UPF1 from coding sequences causes its enrichment in 3′ UTRs. Nat. Struct. Mol. Biol. 2013;20:936–943. doi: 10.1038/nsmb.2635. PubMed DOI

Lee S.R., Pratt G.A., Martinez F.J., Yeo G.W., Lykke-Andersen J. Target Discrimination in Nonsense-Mediated mRNA Decay Requires Upf1 ATPase Activity. Mol. Cell. 2015;59:413–425. doi: 10.1016/j.molcel.2015.06.036. PubMed DOI PMC

Hoernes T.P., Clementi N., Juen M.A., Shi X., Faserl K., Willi J., Gasser C., Kreutz C., Joseph S., Lindner H., et al. Atomic mutagenesis of stop codon nucleotides reveals the chemical prerequisites for release factor-mediated peptide release. Proc. Natl. Acad. Sci. USA. 2018;115:E382–E389. doi: 10.1073/pnas.1714554115. PubMed DOI PMC

Cerami E., Gao J., Dogrusoz U., Gross B.E., Sumer S.O., Aksoy B.A., Jacobsen A., Byrne C.J., Heuer M.L., Larsson E., et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012;2:401–404. doi: 10.1158/2159-8290.CD-12-0095. PubMed DOI PMC

Waterhouse A., Bertoni M., Bienert S., Studer G., Tauriello G., Gumienny R., Heer F.T., De Beer T.A.P., Rempfer C., Bordoli L., et al. SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46:W296–W303. doi: 10.1093/nar/gky427. PubMed DOI PMC

Brooks B.R., Brooks C.L., III, MacKerell A.D., Jr., Nilsson L., Petrella R.J., Roux B., Won Y., Archontis G., Bartels C., Boresch S., et al. CHARMM: The biomolecular simulation program. J. Comput. Chem. 2009;30:1545–1614. doi: 10.1002/jcc.21287. PubMed DOI PMC

Bjelkmar P., Larsson P., Cuendet M.A., Hess B., Lindahl E. Implementation of the CHARMM Force Field in GROMACS: Analysis of Protein Stability Effects from Correction Maps, Virtual Interaction Sites, and Water Models. J. Chem. Theory Comput. 2010;6:459–466. doi: 10.1021/ct900549r. PubMed DOI

Hess B., Kutzner C., van der Spoel D., Lindahl E. GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J. Chem. Theory Comput. 2008;4:435–447. doi: 10.1021/ct700301q. PubMed DOI

Jo S., Kim T., Iyer V.G., Im W. CHARMM-GUI: A web-based graphical user interface for CHARMM. J. Comput. Chem. 2008;29:1859–1865. doi: 10.1002/jcc.20945. PubMed DOI

MacKerell A.D., Bashford D., Bellott M., Dunbrack R.L., Evanseck J.D., Field M.J., Fischer S., Gao J., Guo H., Ha S., et al. All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of Proteins. J. Phys. Chem. B. 1998;102:3586–3616. doi: 10.1021/jp973084f. PubMed DOI

Berendsen H.J.C., Postma J.P.M., van Gunsteren W.F., Hermans J. Interaction Models for Water in Relation to Protein Hydration. In: Pullman B., editor. Intermolecular Forces. The Jerusalem Symposia on Quantum Chemistry and Biochemistry. Volume 14. Springer; Dordrecht, The Netherlands: 1981. DOI

Darden T., York D., Pedersen L. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems. J. Chem. Phys. 1993;19:10089–10092. doi: 10.1063/1.464397. DOI

Bussi G., Donadio D., Parrinello M. Canonical sampling through velocity rescaling. J. Chem. Phys. 2007;126:014101. doi: 10.1063/1.2408420. PubMed DOI

Parrinello M., Rahman A. Polymorphic transitions in single crystals: A new molecular dynamics method. J. Appl. Phys. 1981;52:7182–7190. doi: 10.1063/1.328693. DOI

Van Gunsteren W.F., Berendsen H.J.C. A Leap-frog Algorithm for Stochastic Dynamics. Mol. Simul. 1988;1:173–185. doi: 10.1080/08927028808080941. DOI

Humphrey W., Dalke A., Schulten K. VMD: Visual molecular dynamics. J. Mol. Graph. 1996;14:33–38. doi: 10.1016/0263-7855(96)00018-5. PubMed DOI

In Vitro Cross-Linking MS Reveals SMG1-UPF2-SMG7 Assembly as Molecular Partners within the NMD Surveillance